Source: Eur Respir J, 56 (4) 2002672; 10.1183/13993003.02672-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Jianping Bi, Hong Ma, Dongsheng Zhang, Jing Huang, Dongqin Yang, Yajie Wang, Vivek Verma, Tao Zhang, Desheng Hu, Qi Mei, Guang Han, Jian Li. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?. Eur Respir J, 56 (4) 2002672; 10.1183/13993003.02672-2020

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006 Why can initial treatment of localised lung cancer fail? Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 How soon does tuberculosis in HIV infected patients respond to anti-tuberculous treatment? Source: Annual Congress 2010 - Tuberculosis and HIV coinfection Year: 2010 Who should treat lung cancer patients and where should they be treated? Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009 Second-line treatment patients at relapse of disseminated small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001 A choice of regimen improves completion for patients with latent TB infection Source: Breathe 2008; 4: 366 Year: 2008 The clinical characteristics and treatment responses of tuberculosis in patients with malignancy on anti-cancer chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 On questions of pulmonary tuberculosis relapses among patients completed the directly observed short-course chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Study of patient nominated symptoms and changing symptamatology in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 What outcome after the prescription of neoadjuvant chemotherapy in lung cancer? Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care Year: 2018 Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer? Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Are biphosphonates efficient in the adjuvant treatment of lung cancer? Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006 How do lung cancer patients die? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Is there any place for perioperative radiation therapy? Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004